Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2011Biological and Pharmaceutical BulletinOpen Access

Vascular Endothelial Growth Factor (VEGF), VEGF Receptors and Their Inhibitors for Antiangiogenic Tumor Therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

STSatoru TakahashiUniversity of Tsukuba

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Satoru Takahashi (2011) studied this question.

synapsesocial.com/papers/6a83f7e3f4298de60b3c3d4ehttps://doi.org/10.1248/bpb.34.1785
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prognostic value of vascular endothelial growth factor expression in gastric carcinoma1996 · 633 citations
  2. 2The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing1991 · 1,985 citations
  3. 3VEGFR1 Tyrosine Kinase Signaling Promotes Lymphangiogenesis as Well as Angiogenesis Indirectly via Macrophage Recruitment2008 · 141 citations
  4. 4The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions2005 · 960 citations